400
Participants
Start Date
June 30, 2015
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Patient Reported Outcome (PRO)
Exposure to Quality of Life Questionnaires (EORTC QLQ-LC13, EORTC QLQ-C30 and EQ-5D-5L) every 3 months during standard of care visits.
Research Site, Oceanside
Research Site, Santa Rosa
Research Site, Seongnam
Research Site, JinJoo
Research Site, Ulsan
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY